NAVANAPHAR share price
Navana Pharmaceuticals PLC · Pharmaceuticals & Chemicals · Category A
Price
Closing prices, 19 Nov 2026 Live prices free with an account
- Previous close
- ৳64.80
- Day range
- 64.20 – 65.00
- Volume
- 3,11,090
- Turnover
- ৳2.0Cr
NAVANAPHAR price over the last year
Daily closing prices from DSE, not adjusted for bonus or rights issues.
Reported earnings and NAV
| Period | EPS | NAV / share | NOCFPS |
|---|---|---|---|
| FY27 Q1 | 1.60 | 52.52 | 3.83 |
| FY26 Annual | 5.93 | 51.06 | 18.59 |
| FY26 Q3 | 1.22 | 49.53 | 15.44 |
| FY26 Q2 | 1.65 | 48.32 | 8.11 |
| FY26 Q1 | 1.69 | 47.03 | 5.08 |
| FY25 Annual | 4.54 | 45.29 | 16.90 |
| FY25 Q3 | 1.01 | 45.32 | 10.22 |
| FY25 Q2 | 1.00 | 44.10 | 3.16 |
Per-share figures in taka, as published on DSE. Interim EPS is for the period, not annualised.
Latest DSE announcements
-
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 22.11.2026 to 23.11.2026 and trading of the shares will remain suspended on record date i.e., 24.11.2026.
-
National Credit Ratings Limited (NCR) has assigned Surveillance entity rating of the Company as "AA" in the long term and "ST-2" in the short term along with Stable outlook based on audited financial statements as on June 30, 2026 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
-
(Q1 Un-audited): Basic EPS was Tk. 1.60 for July-September 2026 as against Tk. 1.71 for July-September 2025. Diluted EPS was Tk. 1.59 for July-September 2026 as against Tk. 1.69 (restated) for July-September 2025. NOCFPS was Tk. 3.83 for July-September 2026 as against Tk. 5.08 for July-September 2025. NAV per share was Tk. 52.52 as on September 30, 2026 and Tk. 51.06 as on June 30, 2026. (cont.)
-
(Cont. News of NAVANAPHAR): Reasons for deviation: EPS: The increase in operating expenses (factory and distribution overheads) due to inflationary pressures has resulted in a decrease in EPS. NOCFPS: The decrease in NOPCFPS is primarily attributable to an increase in trade receivables and advances, along with a reduction in trade payables, resulting in lower net cash flow from operating activities. (end)
-
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2026 at 3:30 PM to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended September 30, 2026.
-
The Board of Directors has recommended 6% Cash Dividend and 8% Stock Dividend i.e. 14% Dividend only for the year ended June 30, 2026. Date of AGM: 20.12.2026, Time: 10:00 A.M., Venue & Mode: To be communicated in due course. Record Date: 24.11.2026. The Company has also reported EPS of Tk. 5.93, NAV per share of Tk. 51.06 and NOCFPS of Tk. 18.59 for the year ended June 30, 2026 as against Tk. 4.54, Tk. 45.29 and Tk. 16.90 respectively for the year ended June 30, 2025. (cont.)
Other Pharmaceuticals & Chemicals shares
| Ticker | Price | % | Turnover |
|---|---|---|---|
| ASIATICLABAsiatic Laboratories Limited | 116.70 | +1.83% | ৳16.3Cr |
| WATACHEMWata Chemicals Limited | 183.10 | +8.22% | ৳11.0Cr |
| SQURPHARMASquare Pharmaceuticals PLC. | 209.70 | -0.29% | ৳8.4Cr |
| ACMELABThe ACME Laboratories Limited | 77.50 | -3.73% | ৳3.2Cr |
| ORIONINFUOrion Infusion Ltd. | 202.80 | -0.44% | ৳2.9Cr |
| ACMEPLACME Pesticides Limited | 24.50 | -0.41% | ৳2.8Cr |
NAVANAPHAR: common questions
What is NAVANAPHAR's share price?
NAVANAPHAR closed at ৳64.80 on the Dhaka Stock Exchange (Closing prices, 19 Nov 2026), 0.00 (0.00%) from the previous close of ৳64.80.
What is NAVANAPHAR's 52-week high and low?
Between 23 Nov 2025 and 19 Nov 2026, NAVANAPHAR traded as high as ৳78 and as low as ৳48.10 on DSE.
What is NAVANAPHAR's P/E ratio?
At ৳64.80, NAVANAPHAR's P/E ratio is 10.93, on its FY26 earnings per share of ৳5.93.
What dividend did NAVANAPHAR declare?
For 2026, Navana Pharmaceuticals PLC declared a 6% cash and 8% stock dividend. Percentages are of the ৳10 face value.
Which sector is NAVANAPHAR in?
Navana Pharmaceuticals PLC is listed in the Pharmaceuticals & Chemicals sector of the Dhaka Stock Exchange, in category A.
Prices, trades and company figures are from the Dhaka Stock Exchange; prices are at least 15 minutes old. Trakkr is not affiliated with DSE, and nothing here is investment advice.